SIA
CELG

Stancorp Investment Advisers’s Celgene Corp CELG Stock Holding History

Stancorp Investment Advisers’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$46K Hold
400
– – 0.02% 288
2014
Q4 		$45K Buy
+400
New +$42.2K 0.02% 269

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stancorp Investment Advisers's CELG Position: Q1 2015 in Review

Stancorp Investment Advisers held its Celgene Corp (CELG) position steady in Q1 2015 at 400 shares worth $46K. The position accounts for 0.02% of the portfolio, ranked #288.

Stancorp Investment Advisers first reported a position in CELG in Q4 2014 and has held it in 2 quarters since. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

  • Stancorp Investment Advisers held 400 shares of Celgene Corp worth $46K as of Q1 2015.
  • Stancorp Investment Advisers left its Celgene Corp share count unchanged in Q1 2015.
  • Celgene Corp made up 0.02% of Stancorp Investment Advisers's portfolio in Q1 2015, its #288 holding.
  • Stancorp Investment Advisers first reported a position in Celgene Corp in Q4 2014 and has held it in 2 quarters since.
  • 1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.